Advertisement

Oropharynx, Nasopharynx, and Waldeyer Ring

  • Karan SalujaEmail author
  • Danielle Elliott Range
  • Adel K. El-Naggar
Chapter
Part of the Practical Anatomic Pathology book series (PAP)

Abstract

The pharynx comprises two anatomic sites, the oropharynx and nasopharynx, which contain mucosal and lymphoid tissues. Both regions are sites of some of the most well-studied viral-associated malignancies, including human papillomavirus-related oropharyngeal carcinomas and Epstein-Barr virus-related nasopharyngeal carcinomas. In this chapter, we will discuss the classification and pathogenesis of the most common carcinomas of the pharynx and recent advances in ancillary testing of these entities.

Keywords

Nasopharynx Oropharynx Waldeyer ring Benign squamous tumor Human papillomavirus Oropharyngeal carcinoma HPV-associated oropharyngeal squamous cell carcinoma Non-HPV-associated oropharyngeal squamous cell carcinoma Nasopharyngeal carcinoma Nonkeratinizing nasopharyngeal carcinoma Adenocarcinomas of the pharynx Juvenile angiofibroma Hematolymphoid tumors of the pharynx 

Notes

Disclosures

No financial support was needed for the preparation of this chapter. There was no conflict of interest.

References

  1. 1.
    Lee AWM, Lydiatt WM, Colevas AD, Glastonbury CM, Weber RS, Shah JP. Nasopharynx. In: Amin MB, editor. AJCC Cancer staging manual. 8th ed. New York: Springer; 2017. p. 103–11.CrossRefGoogle Scholar
  2. 2.
    Lydiatt WM, Ridge JA, Patel SG, Brizel DM, Haughey BH, Glastonbury CM, et al. Oropharynx (p16-) and hypopharynx. In: Amin MB, editor. AJCC cancer staging manual. 8th ed. New York: Springer; 2017. p. 123–35.CrossRefGoogle Scholar
  3. 3.
    Wenig BM. Embryology, anatomy, and histology of the pharynx. In: Wenig BM, editor. Atlas of head and neck pathology. 3rd ed. Philadelphia: Elsevier; 2016. p. 399–406.Google Scholar
  4. 4.
    Westra WH, Boy S, El-Mofty SK, Gillison M, Schwartz MR, Syrjanen S, et al. Tumours of the oropharynx (base of tongue, tonsils, adenoids). In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon.: WHO Press: IARC; 2017. p. 136–8.Google Scholar
  5. 5.
    Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Pringle GA. The role of human papillomavirus in oral disease. Dent Clin N Am. 2014;58(2):385–99.CrossRefGoogle Scholar
  7. 7.
    Stojanov IJ, Woo SB. Human papillomavirus and Epstein-Barr virus-associated conditions of the oral mucosa. Semin Diagn Pathol. 2015;32(1):3–11.CrossRefGoogle Scholar
  8. 8.
    Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015;32(1):54–73.CrossRefGoogle Scholar
  9. 9.
    Chan JK. Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems. Mod Pathol. 2017;30(s1):S68–s83.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Prabhu SR, Wilson DF. Human papillomavirus and oral disease – emerging evidence: a review. Aust Dent J. 2013;58(1):2–10; quiz 125.CrossRefPubMedGoogle Scholar
  11. 11.
    Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma – an update. CA Cancer J Clin. 2015;65(5):401–21.CrossRefPubMedGoogle Scholar
  13. 13.
    Joseph AW, D’Souza G. Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin N Am. 2012;45(4):739–64.CrossRefGoogle Scholar
  14. 14.
    Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261–9.CrossRefPubMedGoogle Scholar
  15. 15.
    O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440–51.CrossRefPubMedGoogle Scholar
  16. 16.
    Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker LM, Sarlis NJ, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol. 2011;22(5):1071–7.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res. 2005;11(16):5694–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Bishop JA, Westra WH. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol. 2011;35(11):1679–84.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    El-Mofty SK. Human papillomavirus-related head and neck squamous cell carcinoma variants. Semin Diagn Pathol. 2015;32(1):23–31.CrossRefPubMedGoogle Scholar
  20. 20.
    Gillison ML, D’Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100(6):407–20.CrossRefPubMedGoogle Scholar
  21. 21.
    Kraft S, Faquin WC, Krane JF. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior. Am J Surg Pathol. 2012;36(3):321–30.CrossRefPubMedGoogle Scholar
  22. 22.
    Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998;90(21):1626–36.CrossRefPubMedGoogle Scholar
  23. 23.
    Westra WH. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol. 2014;50(9):771–9.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lewis JS Jr, Scantlebury JB, Luo J, Thorstad WL. Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers. Am J Surg Pathol. 2012;36(7):1036–46.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Thompson LD. Histologically significant features in 390 oropharyngeal squamous cell carcinoma. Lab Investig. 2018;98(suppl 1):488.Google Scholar
  26. 26.
    Rettig EM, D'Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24(3):379–96.CrossRefPubMedGoogle Scholar
  27. 27.
    Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res. 2003;9(17):6469–75.PubMedGoogle Scholar
  28. 28.
    Bishop JA, Lewis JS Jr, Rocco JW, Faquin WC. HPV-related squamous cell carcinoma of the head and neck: an update on testing in routine pathology practice. Semin Diagn Pathol. 2015;32(5):344–51.CrossRefPubMedGoogle Scholar
  29. 29.
    El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2012;34(4):459–61.CrossRefPubMedGoogle Scholar
  30. 30.
    Galloway DA, Laimins LA. Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol. 2015;14:87–92.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Lewis JS Jr. p16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2012;6(Suppl 1):S75–82.CrossRefGoogle Scholar
  32. 32.
    Lewis JS Jr, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med. 2018;142:559–97.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Lewis JS Jr, Thorstad WL, Chernock RD, Haughey BH, Yip JH, Zhang Q, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 2010;34(8):1088–96.CrossRefGoogle Scholar
  34. 34.
    Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–60.CrossRefGoogle Scholar
  35. 35.
    Udager AM, McHugh JB. Human papillomavirus-associated neoplasms of the head and neck. Surg Pathol Clin. 2017;10(1):35–55.CrossRefGoogle Scholar
  36. 36.
    Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35(9):1343–50.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36(12):1874–82.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Walline HM, Komarck C, McHugh JB, Byrd SA, Spector ME, Hauff SJ, et al. High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods. JAMA Otolaryngol Head Neck Surg. 2013;139(12):1320–7.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Westra WH. Detection of human papillomavirus in clinical samples. Otolaryngol Clin N Am. 2012;45(4):765–77.CrossRefGoogle Scholar
  40. 40.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRefPubMedGoogle Scholar
  41. 41.
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet. 1997;350(9084):1087–91.CrossRefPubMedGoogle Scholar
  43. 43.
    Plaza G, Manzanal AI, Fogue L, Santon A, Martinez-Montero JC, Bellas C. Association of Epstein-Barr virus and nasopharyngeal carcinoma in Caucasian patients. Ann Otol Rhinol Laryngol. 2002;111(3 Pt 1):210–6.CrossRefPubMedGoogle Scholar
  44. 44.
    Tsai ST, Jin YT, Mann RB, Ambinder RF. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer. 1998;82(8):1449–53.CrossRefPubMedGoogle Scholar
  45. 45.
    Ou SH, Zell JA, Ziogas A, Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007;18(1):29–35.CrossRefPubMedGoogle Scholar
  46. 46.
    Kamran SC, Riaz N, Lee N. Nasopharyngeal carcinoma. Surg Oncol Clin N Am. 2015;24(3):547–61.CrossRefPubMedGoogle Scholar
  47. 47.
    Colaco RJ, Betts G, Donne A, Swindell R, Yap BK, Sykes AJ, et al. Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol (R Coll Radiol (Great Brit)). 2013;25(3):171–7.CrossRefGoogle Scholar
  48. 48.
    Franchi A, Moroni M, Massi D, Paglierani M, Santucci M. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol. 2002;26(12):1597–604.CrossRefPubMedGoogle Scholar
  49. 49.
    Inoue H, Sato Y, Tsuchiya B, Nagai H, Takahashi H, Kameya T. Expression of Epstein-Barr virus-encoded small nuclear RNA 1 in Japanese nasopharyngeal carcinomas. Acta Otolaryngol Suppl. 2002;547:113–7.CrossRefGoogle Scholar
  50. 50.
    Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol. 1995;146(6):1355–67.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Wenig BM. Lymphoepithelial-like carcinomas of the head and neck. Semin Diagn Pathol. 2015;32(1):74–86.CrossRefGoogle Scholar
  52. 52.
    Stelow EB, Wenig BM. Update from the 4th edition of the World Health Organization classification of head and neck tumours: nasopharynx. Head Neck Pathol. 2017;11(1):16–22.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Verma V, Simone CB 2nd, Lin C. Human papillomavirus and nasopharyngeal cancer. Head Neck. 2018;40(4):696–706.CrossRefPubMedGoogle Scholar
  54. 54.
    Robinson M, Suh YE, Paleri V, Devlin D, Ayaz B, Pertl L, et al. Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population. Infect Agent Cancer. 2013;8(1):30.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Stenmark MH, McHugh JB, Schipper M, Walline HM, Komarck C, Feng FY, et al. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys. 2014;88(3):580–8.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Maxwell JH, Kumar B, Feng FY, McHugh JB, Cordell KG, Eisbruch A, et al. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck. 2010;32(5):562–7.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Zhang WL, Ma S, Havrilla L, Cai L, Yu CQ, Shen S, et al. Primary thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: a case report and literature review. Medicine. 2017;96(47):e8851.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Kuan EC, Alonso JE, Arshi A, St John MA. Nasopharyngeal adenocarcinoma: a population-based analysis. Am J Otolaryngol. 2017;38(3):297–300.CrossRefPubMedGoogle Scholar
  59. 59.
    Goel AN, Badran KW, Braun APG, Garrett AM, Long JL. Minor salivary gland carcinoma of the oropharynx: a population-based analysis of 1426 patients. Otolaryngol Head Neck Surg. 2018;158(2):287–94.CrossRefPubMedGoogle Scholar
  60. 60.
    Carrizo F, Luna MA. Thyroid transcription factor-1 expression in thyroid-like nasopharyngeal papillary adenocarcinoma: report of 2 cases. Ann Diagn Pathol. 2005;9(4):189–92.CrossRefPubMedGoogle Scholar
  61. 61.
    Iyer NG, Kim L, Nixon IJ, Palmer F, Kraus D, Shaha AR, et al. Factors predicting outcome in malignant minor salivary gland tumors of the oropharynx. Arch Otolaryngol Head Neck Surg. 2010;136(12):1240–7.CrossRefPubMedGoogle Scholar
  62. 62.
    Kuo T, Tsang NM. Salivary gland type nasopharyngeal carcinoma: a histologic, immunohistochemical, and Epstein-Barr virus study of 15 cases including a psammomatous mucoepidermoid carcinoma. Am J Surg Pathol. 2001;25(1):80–6.CrossRefPubMedGoogle Scholar
  63. 63.
    O’Sullivan B, Lydiatt WM, Haughey BH, Brandwein-Gensler M, Glastonbury CM, Shah JP. HPV-mediated (p16+) oropharyngeal cancer. In: Amin MB, editor. AJCC cancer staging manual. 8th ed. New York: Springer; 2017. p. 113–21.CrossRefGoogle Scholar
  64. 64.
    Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37.CrossRefPubMedGoogle Scholar
  65. 65.
    Keane FK, Chen YH, Neville BA, Tishler RB, Schoenfeld JD, Catalano PJ, et al. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era. Cancer. 2015;121(15):2594–602.CrossRefPubMedGoogle Scholar
  66. 66.
    Haughey BH, Sinha P, Kallogjeri D, Goldberg RL, Lewis JS Jr, Piccirillo JF, et al. Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol. 2016;62:11–9.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Boghani Z, Husain Q, Kanumuri VV, Khan MN, Sangvhi S, Liu JK, et al. Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases. Laryngoscope. 2013;123(4):859–69.CrossRefPubMedGoogle Scholar
  68. 68.
    Ewing JA, Shively EH. Angiofibroma: a rare case in an elderly female. Otolaryngol Head Neck Surg. 1981;89(4):602–3.CrossRefPubMedGoogle Scholar
  69. 69.
    Ferouz AS, Mohr RM, Paul P. Juvenile nasopharyngeal angiofibroma and familial adenomatous polyposis: an association? Otolaryngol Head Neck Surg. 1995;113(4):435–9.CrossRefPubMedGoogle Scholar
  70. 70.
    Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11(11):1122–6.Google Scholar
  71. 71.
    Neel HB 3rd, Whicker JH, Devine KD, Weiland LH. Juvenile angiofibroma. Review of 120 cases. Am J Surg. 1973;126(4):547–56.CrossRefGoogle Scholar
  72. 72.
    Patrocinio JA, Patrocinio LG, Borba BH, Bonatti Bde S, Guimaraes AH. Nasopharyngeal angiofibroma in an elderly woman. Am J Otolaryngol. 2005;26(3):198–200.CrossRefGoogle Scholar
  73. 73.
    Cox DP, Daniels T, Jordan RC. Solitary fibrous tumor of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(1):79–84.CrossRefGoogle Scholar
  74. 74.
    Dandekar M, McHugh JB. Sinonasal glomangiopericytoma: case report with emphasis on the differential diagnosis. Arch Pathol Lab Med. 2010;134(10):1444–9.Google Scholar
  75. 75.
    Lasota J, Felisiak-Golabek A, Aly FZ, Wang ZF, Thompson LD, Miettinen M. Nuclear expression and gain-of-function beta-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker. Mod Pathol. 2015;28(5):715–20.CrossRefGoogle Scholar
  76. 76.
    Mohajeri A, Tayebwa J, Collin A, Nilsson J, Magnusson L, von Steyern FV, et al. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer. 2013;52(10):873–86.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Porter PL, Bigler SA, McNutt M, Gown AM. The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. Mod Pathol. 1991;4(1):46–52.Google Scholar
  78. 78.
    Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013;45(2):180–5.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003;27(6):737–49.CrossRefGoogle Scholar
  80. 80.
    Thakral B, Zhou J, Medeiros LJ. Extranodal hematopoietic neoplasms and mimics in the head and neck: an update. Hum Pathol. 2015;46(8):1079–100.CrossRefPubMedGoogle Scholar
  81. 81.
    Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am. 2003;13(3):371–92.CrossRefPubMedGoogle Scholar
  82. 82.
    Tonyali O, Sumbul AT, Ozturk MA, Koyuncuer A, Ekiz F. A case of rectal adenocarcinoma presented with palatine tonsil metastasis. J Oncol Pharm Pract. 2016;22(2):341–3.CrossRefPubMedGoogle Scholar
  83. 83.
    Cheng X, Hu Z, Han Y, Bai C. A case report of tongue metastasis from lung squamous cell carcinoma and literature review. Medicine. 2017;96(40):e8208.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Billan S, Abdah-Bortnyak R, Stein ME, Kuten A. Base of the tongue metastasis: aggressive behavior of triple-negative breast carcinoma. Isr Med Assoc J. 2009;11(4):250.PubMedGoogle Scholar
  85. 85.
    Marcotullio D, Iannella G, Macri GF, Marinelli C, Zelli M, Magliulo G. Renal clear cell carcinoma and tonsil metastasis. Case Rep Otolaryngol. 2013;2013:315157.PubMedPubMedCentralGoogle Scholar
  86. 86.
    Cecchi R, Pavesi M, Calamandrei P, Rapicano V, De Gaudio C. Tonsil metastasis from cutaneous melanoma: first clinical sign of recurrence after complete lymph node dissection. J Cutan Med Surg. 2010;14(1):43–5.CrossRefPubMedGoogle Scholar
  87. 87.
    Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009;3(3):186–94.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Fujimaki M, Fukumura Y, Mitani K, Kurisaki A, Yokoyama J, Ikeda K, et al. Histological subtypes and characteristic structures of HPV-associated oropharyngeal carcinoma: study with Japanese cases. Diagn Pathol. 2013;8:211.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Massaccesi M, Morganti AG, Serafini G, Di Lallo A, Deodato F, Picardi V, et al. Late tonsil metastases from renal cell cancer: a case report. Tumori. 2009;95(4):521–4.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Karan Saluja
    • 1
    Email author
  • Danielle Elliott Range
    • 2
  • Adel K. El-Naggar
    • 3
  1. 1.The University of Texas, Health Science Center, McGovern Medical School, Department of Pathology and Laboratory MedicineHoustonUSA
  2. 2.Duke Health, Duke University Medical Center, Department of Pathology, Section of Head and Neck and Endocrine PathologyDurhamUSA
  3. 3.The University of Texas MD Anderson Cancer Center, Department of Pathology, Division of Pathology and Laboratory MedicineHoustonUSA

Personalised recommendations